Performance data is updated to 30 April 2026.
Vanguard Global Value Equity Active ETF.
In pursuit of its investment objective, Vanguard uses a proprietary quantitative model to evaluate an investment universe comprised of large, mid and small cap equity securities from developed markets across the world, which includes a diverse representation of companies, market sectors and industry groups. This investment universe is drawn primarily from equity securities included in the FTSE Developed All Cap Index and the Russell 3000 Index. Vanguard’s quantitative model implements a rules-based active approach that aims to assess the factor exposures of securities, favouring equity securities which, when compared to other securities in the investment universe, have lower prices relative to their fundamental measures of value (measures may include price-to-book, price-to-earnings ratio and price-to-operating cash flow).
Performance (% return)
Investment Focus
Exposure Regions
Portfolio Breakdown
| Symbol | Company Name | % assets |
|---|---|---|
| VZ | Verizon Communications Inc | 0.73% |
| BMY | Bristol-Myers Squibb Co | 0.66% |
| T | AT&T Inc | 0.65% |
| CMCSA | Comcast Corp | 0.64% |
| PFE | Pfizer Inc | 0.60% |
| FDX | FedEx Corp | 0.58% |
| GM | General Motors Co | 0.55% |
| CVS | CVS Health Corp | 0.51% |
| MRK | Merck & Co Inc | 0.50% |
| CI | Cigna Group/The | 0.50% |
| Sector | % assets |
|---|---|
| Financials | 22.6% |
| Consumer Discretionary | 18.8% |
| Health Care | 12.3% |
| Industrials | 11.2% |
| Energy | 10.7% |
| Consumer Staples | 7.3% |
| Basic Materials | 6.9% |
| Technology | 5.4% |
| Telecommunications | 4.1% |
| Real Estate | 0.6% |
| Utilities | 0.1% |
| Region/Country | % assets |
|---|---|
| North America | 72.6% |
| Europe | 15.9% |
| Pacific | 10.7% |
| Middle East | 0.8% |
| Emerging Markets | 0% |
Similar ETFs
| Stock | Name | 1 Year % |
|---|---|---|
| BGBL | Global Shares ETF | +15.26% |
| DFND | VanEck Global Defence ETF | +18.31% |
| ARMR | Global Defence ETF | +14.76% |
| BNKS | Global Banks Currency Hedged ETF | +42.18% |
| DRUG | BetaShares Global Healthcare Currency Hedged ETF | +4.52% |
Disclaimer
The information provided on ReviewETF.com.au is intended for general information and comparison purposes only. It is compiled and presented on a best-endeavours basis from publicly available sources, but we do not guarantee its accuracy, completeness, timeliness, or suitability for any particular purpose.
No content on this website constitutes financial advice, investment recommendation, solicitation, or an offer to buy or sell any securities. Past performance is not indicative of future results, and all investments carry risk, including the potential loss of capital.
The point of truth for any ETF is always the official product disclosure statement (PDS), website, and announcements from the ETF issuer/provider (e.g., Vanguard, BetaShares, iShares, VanEck, etc.). We link directly to these primary sources on each individual ETF page wherever possible—please verify all details there before making any decisions.
ReviewETF.com.au, its owner (Joshua), and any associated entities disclaim all liability for any loss or damage arising from the use of, or reliance on, information contained on this site. Users should seek independent professional financial advice tailored to their personal circumstances.
This website may contain links to third-party sites; we are not responsible for their content or privacy practices.
Last updated: January 2026
